{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:54:43Z","timestamp":1791057283790,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.oret.2026.08.029","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:47:10Z","timestamp":1788479230000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes"],"prefix":"10.1016","author":[{"given":"Jessica J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1799-7233","authenticated-orcid":false,"given":"Todd","family":"Brothers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-6416","authenticated-orcid":false,"given":"Leo A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6720-3035","authenticated-orcid":false,"given":"Kristina E.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafizan","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-7895","authenticated-orcid":false,"given":"Xuerong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2026.08.029_bib1","series-title":"Becker\u2019s Hospital review | Healthcare News & Analysis","author":"Twenter","year":"2025"},{"key":"10.1016\/j.oret.2026.08.029_bib2","series-title":"Poll: 1 in 8 adults say they\u2019ve taken a GLP-1 drug, including 4 in 10 of those with diabetes and 1 in 4 of those with heart disease","year":"2024"},{"key":"10.1016\/j.oret.2026.08.029_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.oret.2026.08.029_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","article-title":"Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California","volume":"14","author":"Johnson","year":"1994","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy","volume":"123","author":"Hattenhauer","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib8","series-title":"NAION: diagnosis and management","year":"2022"},{"key":"10.1016\/j.oret.2026.08.029_bib9","article-title":"Risk factors for non-arteritic anterior ischemic optic neuropathy: a large-scale meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.oret.2026.08.029_bib10","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4103\/0366-6999.241795","article-title":"Systemic-related factors of nonarteritic anterior ischemic optic neuropathy","volume":"131","author":"Xiao","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.oret.2026.08.029_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ophtha.2011.01.054","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients","volume":"118","author":"Lee","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2026.08.029_bib12","series-title":"StatPearls","article-title":"Nonarteritic anterior ischemic optic neuropathy","author":"Kaur","year":"2025"},{"key":"10.1016\/j.oret.2026.08.029_bib13","first-page":"72","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview","volume":"7","author":"Salvetat","year":"2023","journal-title":"Vis Basel Switz"},{"key":"10.1016\/j.oret.2026.08.029_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaophthalmol.2024.6555","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy","volume":"143","author":"Cai","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajo.2025.02.025","article-title":"The effect of semaglutide and GLP-1 RAs on the risk of nonarteritic anterior ischemic optic neuropathy","volume":"274","author":"Abbass","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib17","article-title":"Semaglutide and non-arteritic anterior ischemic optic neuropathy: a systematic review","volume":"17","author":"Hidalgo Ramos","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.oret.2026.08.029_bib18","first-page":"991","article-title":"Non-arteritic anterior ischemic optic neuropathy in an otherwise healthy young adult patient treated with liraglutide and semaglutide for weight loss: a cautionary tale","volume":"18","author":"Lixi","year":"2025","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.oret.2026.08.029_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.26327","article-title":"Semaglutide or tirzepatide and optic nerve and visual pathway disorders in type 2 diabetes","volume":"8","author":"Wang","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.oret.2026.08.029_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41433-025-03833-y","article-title":"NAION risk with semaglutide: what we know so far","volume":"39","author":"Hsu","year":"2025","journal-title":"Eye"},{"key":"10.1016\/j.oret.2026.08.029_bib21","doi-asserted-by":"crossref","first-page":"NP10","DOI":"10.1177\/11206721251331655","article-title":"Non arteritic ischemic optic neuropathy in a patient taking semaglutide: is there a relation? A case report and a review of the literature","volume":"35","author":"Maceroni","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214864","article-title":"Glucagon-like peptide-1 receptor agonists and risk of nonarteritic anterior ischemic optic neuropathy: systematic review and meta-analysis","volume":"106","author":"Dhivagaran","year":"2026","journal-title":"Neurology"},{"key":"10.1016\/j.oret.2026.08.029_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/dc25-1238","article-title":"Association between GLP-1 receptor agonists and ischemic optic neuropathy: a meta-analysis","volume":"49","author":"Nogueira","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2026.08.029_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2337\/dc25-2577","article-title":"Glucagon-like peptide-1 receptor agonists and risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes","volume":"49","author":"Noh","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2026.08.029_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamaophthalmol.2025.6262","article-title":"New-onset nonarteritic anterior ischemic optic neuropathy and initiators of semaglutide in US Veterans with type 2 diabetes","volume":"144","author":"Heberer","year":"2026","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamaophthalmol.2025.2299","article-title":"GLP-1 RAs and risk of nonarteritic anterior ischemic optic neuropathy in older patients with diabetes","volume":"143","author":"Fung","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ophtha.2026.02.013","article-title":"Semaglutide and the risk of nonarteritic ischemic optic neuropathy: a systematic review and certainty of evidence meta-analysis","volume":"133","author":"Abdelaal","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2026.08.029_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40618-025-02712-3","article-title":"Multi-database pharmacovigilance assessment of GLP-1 receptor agonist-related ophthalmic risks using advanced signal detection in FAERS and vigibase","volume":"49","author":"Cheng","year":"2026","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.oret.2026.08.029_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2025.05.007","article-title":"Association of glucagon-like peptide-1 receptor agonists with optic nerve and retinal adverse events: a population-based observational study across 180 countries","volume":"277","author":"Lakhani","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12886-025-04096-7","article-title":"Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/jpm12030454","article-title":"Sex differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care","volume":"12","author":"Rentzeperi","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.oret.2026.08.029_bib32","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae165","article-title":"GLP-1 and its analogs: does sex matter?","volume":"166","author":"B\u00f6rchers","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.oret.2026.08.029_bib33","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2026.08.029_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/WNO.0000000000000971","article-title":"Validity of International Classification of Diseases Codes for identifying neuro-ophthalmic disease in large data sets: a systematic review","volume":"40","author":"Hamedani","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/WNO.0000000000002163","article-title":"Validity of administrative coding for nonarteritic ischemic optic neuropathy","volume":"44","author":"Hamedani","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib36","series-title":"StatPearls","article-title":"Non-arteritic anterior ischemic optic neuropathy","author":"Raizada","year":"2025"},{"key":"10.1016\/j.oret.2026.08.029_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5664\/jcsm.2766","article-title":"Obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: evidence for an association","volume":"9","author":"Archer","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.oret.2026.08.029_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2025.101664","article-title":"What the diabetologist needs to know about the risk of non-arteritic anterior ischemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes","volume":"51","author":"Feldman-Billard","year":"2025","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.oret.2026.08.029_bib39","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/j.oret.2026.08.029_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ophtha.2024.10.030","article-title":"Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study","volume":"132","author":"Chou","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2026.08.029_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40942-024-00620-x","article-title":"Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes","volume":"10","author":"Grauslund","year":"2024","journal-title":"Int J Retina Vitr"},{"key":"10.1016\/j.oret.2026.08.029_bib42","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1111\/dom.16316","article-title":"Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: a Danish-Norwegian cohort study","volume":"27","author":"Simonsen","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.oret.2026.08.029_bib43","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/19322968241268050","article-title":"Real-world evidence assessment of the risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"18","author":"Klonoff","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.oret.2026.08.029_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.2005.083519","article-title":"Non-arteritic anterior ischemic optic neuropathy and the treatment of erectile dysfunction","volume":"90","author":"McGwin","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib45","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2147\/OPTH.S21243","article-title":"A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil","volume":"5","author":"Felekis","year":"2011","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.oret.2026.08.029_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12886-025-03958-4","article-title":"Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association","volume":"25","author":"Ahmadi","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/jamaophthalmol.2025.2332","article-title":"GLP-1RA exposure and nonarteritic anterior ischemic optic neuropathy prevalence by diabetes status","volume":"143","author":"Nagdeve","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib48","author":"Bartelt"},{"key":"10.1016\/j.oret.2026.08.029_bib49","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1111\/dom.70160","article-title":"Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensus","volume":"27","author":"Carter","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.oret.2026.08.029_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","article-title":"GLP-1 receptor activated insulin secretion from pancreatic \u03b2-cells: mechanism and glucose dependence","volume":"15","author":"Meloni","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.oret.2026.08.029_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.oret.2026.08.029_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.61.5.9","article-title":"Differentiation of nonarteritic anterior ischemic optic neuropathy from normal-tension glaucoma by comparison of the lamina cribrosa","volume":"61","author":"Kim","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2026.08.029_bib53","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archopht.1991.01080120052024","article-title":"Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles","volume":"109","author":"Rizzo","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2026.08.029_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/eye.2014.144","article-title":"Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy","volume":"29","author":"Miller","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2026.08.029_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.exer.2014.12.006","article-title":"The role of lamina cribrosa cells in optic nerve head fibrosis in glaucoma","volume":"142","author":"Wallace","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oret.2026.08.029_bib56","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1167\/iovs.07-0171","article-title":"Optic disc evaluation by optical coherence tomography in nonarteritic anterior ischemic optic neuropathy","volume":"48","author":"Contreras","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2026.08.029_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08820538.2019.1620792","article-title":"Disc configuration as a risk and prognostic factor in NAION: the impact of cup-to-disc ratio, disc diameter, and crowding index","volume":"34","author":"Gonz\u00e1lez Mart\u00edn-Moro","year":"2019","journal-title":"Semin Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026004355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026004355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:40:11Z","timestamp":1791056411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653026004355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S2468653026004355"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.08.029","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}